Oxazolidinone Antibacterials and Our Experience

ISSN: 2211-3533 (Online)
ISSN: 2211-3525 (Print)

Volume 15, 2 Issues, 2017

Download PDF Flyer

Anti-Infective Agents

Formerly: Anti-Infective Agents in Medicinal Chemistry

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Oxazolidinone Antibacterials and Our Experience

Anti-Infective Agents, 7(4): 258-280.

Author(s): Brijesh Kumar Srivastava, Rina Soni, Jayendra Z. Patel, Mukul R. Jain and Pankaj R Patel.

Affiliation: Zydus Research Centre, Cadila Healthcare Ltd., Sarkhej-Bavla N.H. 8A, Moraiya, Ahmedabad- 382210, Gujarat, India.


The Oxazolidinones are a promising novel chemical synthetic class of antibiotics identified in the last two decades and have been subjected to intensive discovery efforts. They possess impressive antibacterial activity against Grampositive pathogens. Oxazolidinones act through a unique mechanism of inhibitory bacterial protein biosynthesis. Linezolid (ZyvoxTM) has been the only drug of oxazolidinone class to reach the market after USFDA approval. Here we review our efforts directed to the discovery of novel oxazolidinone antibacterials evolved through structure-activity relationship (SAR) and an overview of contemporary on going efforts.


Oxazolidinones, Antibacterials, antibiotics, structure-activity relationship (SAR), antibacterial activity, synthetic compound.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 7
Issue Number: 4
First Page: 258
Last Page: 280
Page Count: 23
DOI: 10.2174/187152108785908820
Price: $58

Related Journals

Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science